Eagle Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC EGRX

Report date

6/30/2024

Quarter

2024 Q2

Filed

8/12/2024

Shares

50,589

Value ($000)

283

Weight

0.0%

2019 Q4 - 2024 Q2 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q2	8/12/2024	283	0.0%	50,589	6/30/2024
2024 Q1	5/9/2024	387	0.0%	73,927	3/31/2024
2023 Q4	2/6/2024	378	0.0%	72,282	12/31/2023
2023 Q3	11/8/2023	1,740	0.0%	110,354	9/30/2023
2023 Q2	8/10/2023	2,074	0.0%	106,675	6/30/2023
2023 Q1	5/12/2023	3,068	0.0%	108,129	3/31/2023
2022 Q4	2/13/2023	4,762	0.0%	162,931	12/31/2022
2022 Q3	11/14/2022	3,782	0.0%	143,124	9/30/2022
2022 Q2	8/15/2022	5,443	0.0%	122,494	6/30/2022
2022 Q1	5/13/2022	5,472	0.0%	110,564	3/31/2022
2021 Q4	2/11/2022	4,947	0.0%	97,142	12/31/2021
2021 Q3	11/16/2021	4,527	0.0%	81,143	9/30/2021
2021 Q2	8/16/2021	3,452	0.0%	80,656	6/30/2021
2021 Q1	5/17/2021	3,215	0.0%	77,003	3/31/2021
2020 Q4	2/16/2021	3,502	0.0%	75,194	12/31/2020
2020 Q3	11/13/2020	3,250	0.0%	76,493	9/30/2020
2020 Q2	8/20/2020	3,272	0.0%	68,194	6/30/2020
2020 Q1	5/15/2020	2,767	0.0%	60,147	3/31/2020
2019 Q4	2/7/2020	6,597	0.0%	109,787	12/31/2019